John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


  1. Published

    Limb girdle muscular dystrophy due to mutations in POMT2

    Østergaard, S. T., Johnson, K., Stojkovic, T., Krag, T., De Ridder, W., De Jonghe, P., Baets, J., Claeys, K. G., Fernández-Torrón, R., Phillips, L., Topf, A., Colomer, J., Nafissi, S., Jamal-Omidi, S., Bouchet-Seraphin, C., Leturcq, F., MacArthur, D. G., Lek, M., Xu, L., Nelson, I. & 2 others, Straub, V. & Vissing, John, 2018, In: Journal of neurology, neurosurgery, and psychiatry. 89, 5, p. 506-512

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Bezafibrate in skeletal muscle fatty acid oxidation disorders: A randomized clinical trial

    Ørngreen, M. C., Madsen, K. L., Preisler, N., Andersen, G., Vissing, John & Laforêt, P., 18 Feb 2014, In: Neurology. 82, 7, p. 607-613 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    No effect of bezafibrate in patients with CPTII and VLCAD deficiencies

    Ørngreen, M. C., Vissing, John & Laforét, P., Mar 2015, In: Journal of Inherited Metabolic Disease. 38, 2, p. 373-4 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. Published

    Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease)

    Ørngreen, M. C., Jeppesen, T. D., Taivassalo, T., Hauerslev, S., Preisler, N., Heinicke, K., Haller, R. G., Vissing, John & van Hall, Gerrit, Aug 2015, In: Journal of Clinical Endocrinology and Metabolism. 100, 8, p. E1096-E1104 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Treatment Opportunities in Patients With Metabolic Myopathies

    Ørngreen, M. C. & Vissing, John, 2017, In: Current Treatment Options in Neurology. 19, 11, 16 p., 37.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Endocrine function in 97 patients with myotonic dystrophy type 1

    Ørngreen, M. C., Arlien-Søborg, P., Duno, M., Hertz, J. M. & Vissing, John, 2012, In: Journal of Neurology. 259, 5, p. 912-20 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Effects of IV glucose and oral medium-chain triglyceride in patients with VLCAD deficiency

    Ørngreen, M. C., Nørgaard, M. G., van Engelen, B. G. M., Vistisen, B., Vissing, John & Charlot, M. G., 17 Jul 2007, In: Neurology. 69, 3, p. 313-5 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency

    ØRngreen, M. C., Nørgaard, M., Sacchetti, M., van Engelen, B. G. M., Vissing, John & Charlot, M. G., 1 Aug 2004, In: Annals of Neurology. 56, 2, p. 279-83 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience

    van der Ploeg, A. T., Kruijshaar, M. E., Toscano, A., Laforêt, P., Angelini, C., Lachmann, R. H., Pascual Pascual, S. I., Roberts, M., Rösler, K., Stulnig, T. M., van Doorn, P. A., Van den Bergh, P. Y. K., Vissing, John, Schoser, B. & European Pompe Consortium, E. P. C., Jun 2017, In: European Journal of Neurology. 24, 6, p. 768-e31

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy

    Zaharieva, I. T., Thor, M. G., Oates, E. C., van Karnebeek, C., Hendson, G., Blom, E., Witting, N., Rasmussen, M., Gabbett, M. T., Ravenscroft, G., Sframeli, M., Suetterlin, K., Sarkozy, A., D'Argenzio, L., Hartley, L., Matthews, E., Pitt, M., Vissing, J., Ballegaard, M., Krarup, C. & 20 others, Slørdahl, A., Halvorsen, H., Ye, X. C., Zhang, L., Løkken, N., Werlauff, U., Abdelsayed, M., Davis, M. R., Feng, L., Phadke, R., Sewry, C. A., Morgan, J. E., Laing, N. G., Vallance, H., Ruben, P., Hanna, M. G., Lewis, S., Kamsteeg, E., Männikkö, R. & Muntoni, F., 2016, In: Brain. 139, 3, p. 674-91 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    222nd ENMC International Workshop: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016

    Wood, L., Bassez, G., van Engelen, B., Lochmüller, H., Schoser, B., 222nd ENMC workshop participants, 2. E. W. P., Atalaiae, A., Balabanovf, P., Bassez, G., Treweek, S., Vissing, John & Wood, L., 2018, In: Neuromuscular Disorders. 28, 5, p. 463-469

    Research output: Contribution to journalComment/debateResearch

  12. Published

    Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype

    Witting, N., Duno, M. & Vissing, John, 2011, In: Acta Myologica. 30, 3, p. 182-4 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Axial myopathy: an overlooked feature of muscle diseases

    Witting, N., Andersen, L. K. & Vissing, John, 2016, In: Brain. 139, 1, p. 13-22 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy

    Witting, N., Kruuse, Christina Rostrup, Nyhuus, B., Prahm, K. P., Citirak, G., Lundgaard, S. J., von Huth, S., Vejlstrup, N., Lindberg, U., Krag, T. O. & Vissing, John, Oct 2014, In: Annals of Neurology. 76, 4, p. 550–557 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Clinical and neurophysiological response to pharmacological treatment of DOK7 congenital myasthenia in an older patient

    Witting, N., Crone, C., Duno, M. & Vissing, John, Mar 2015, In: Clinical Neurology and Neurosurgery. 130, p. 168-70 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Severe Axial Myopathy in McArdle Disease

    Witting, N., Duno, M., Piraud, M. & Vissing, John, Jan 2014, In: J A M A Neurology. 71, 1, p. 88-90 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Pharmacologic Treatment of Downstream of Tyrosine Kinase 7 Congenital Myasthenic Syndrome

    Witting, N. & Vissing, John, Mar 2014, In: Archives of Neurology. 71, 3, p. 350-354 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  18. Published

    Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression

    Witting, N., Duno, M., Petri, H., Krag, T., Bundgård, Henning, Køber, Lars Valeur & Vissing, John, 2013, In: Journal of Neurology. 260, 8, p. 2084-2093 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Collagen XII myopathy with rectus femoris atrophy and collagen XII retention in fibroblasts

    Witting, N., Krag, T., Werlauff, U., Duno, M., Oestergaard, S. T., Dahlqvist, J. R. & Vissing, John, 2018, In: Muscle & Nerve. 57, 6, p. 1026-1030

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    LGMD2L with bone affection: overlapping phenotype of dominant and recessive ANO5-induced disease

    Witting, N., Duno, M., Born, A. P. & Vissing, John, 2012, In: Muscle & Nerve. 46, 5, p. 829-30 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

    Witting, N., Werlauff, U., Duno, M. & Vissing, John, Apr 2017, In: Neurology: Genetics. 3, 2, 15 p., e140.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Prevalence and phenotypes of congenital myopathy due to α-actin 1 gene mutations

    Witting, N., Werlauff, U., Duno, M. & Vissing, John, Mar 2016, In: Muscle & Nerve. 53, 3, p. 388-93 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2

    Witting, N., Duno, M. & Vissing, John, 2013, In: Neuromuscular Disorders. 23, 1, p. 25-8 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    A third case of congenital myasthenic syndrome caused by mutations in SCN4A

    Witting, N., Werlauff, U., Ballegaard, Martin & Vissing, John, Oct 2015, p. S209-S209. 1 p.

    Research output: Contribution to conferencePosterResearchpeer-review

  25. Published

    Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis

    Witting, N., Daugaard, D., Prytz, S., Biernat, H., Diederichsen, Louise C P Raun & Vissing, John, 2022, In: Journal of Neurology. 269, 8, p. 4154-4160 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 915367